118 related articles for article (PubMed ID: 20979862)
1. [Effect of statin therapy on mortality in patients with non-ischemic dilated cardiomyopathy].
Li X; Liu XP; Liu XH; Du X; Kang JP; Lü Q; Wang HY; Xu X; Liang C; Yan Q; Lei T; Geng LL; Liu BQ; Ma CS
Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(28):1974-7. PubMed ID: 20979862
[TBL] [Abstract][Full Text] [Related]
2. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).
Domanski M; Coady S; Fleg J; Tian X; Sachdev V
Am J Cardiol; 2007 May; 99(10):1448-50. PubMed ID: 17493477
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy improves long-term survival in non-ischaemic cardiomyopathy: a pooled analysis of 4500 patients.
Deo SV; Rababa'h A; Altarabsheh SE; Lim JY; Cho YH; Park SJ
Heart Lung Circ; 2014 Oct; 23(10):985-7. PubMed ID: 24851827
[TBL] [Abstract][Full Text] [Related]
4. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
Goldberger JJ; Subacius H; Schaechter A; Howard A; Berger R; Shalaby A; Levine J; Kadish AH;
J Am Coll Cardiol; 2006 Sep; 48(6):1228-33. PubMed ID: 16979011
[TBL] [Abstract][Full Text] [Related]
5. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
Nevzorov R; Novack V; Henkin Y; Kobal SL; Jotkowitz A; Porath A
Eur J Intern Med; 2009 Sep; 20(5):494-8. PubMed ID: 19712852
[TBL] [Abstract][Full Text] [Related]
7. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
Wojnicz R; Wilczek K; Nowalany-Kozielska E; Szyguła-Jurkiewicz B; Nowak J; Poloński L; Dyrbuś K; Badziński A; Mercik G; Zembala M; Wodniecki J; Rozek MM
Am J Cardiol; 2006 Mar; 97(6):899-904. PubMed ID: 16516598
[TBL] [Abstract][Full Text] [Related]
9. Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
Anker SD; Clark AL; Winkler R; Zugck C; Cicoira M; Ponikowski P; Davos CH; Banasiak W; Zardini P; Haass M; Senges J; Coats AJ; Poole-Wilson PA; Pitt B
Int J Cardiol; 2006 Sep; 112(2):234-42. PubMed ID: 16846656
[TBL] [Abstract][Full Text] [Related]
10. A prospective evaluation of the effect of simvastatin on heart rate variability in non-ischemic cardiomyopathy.
Gentlesk PJ; Wiley T; Taylor AJ
Am Heart J; 2005 Sep; 150(3):478-83. PubMed ID: 16169328
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of statins in patients with non-ischemic heart failure.
Laufs U; Wassmann S; Schackmann S; Heeschen C; Böhm M; Nickenig G
Z Kardiol; 2004 Feb; 93(2):103-8. PubMed ID: 14963675
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
Hognestad A; Dickstein K; Myhre E; Snapinn S; Kjekshus J;
Am J Cardiol; 2004 Mar; 93(5):603-6. PubMed ID: 14996587
[TBL] [Abstract][Full Text] [Related]
13. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
Horwich TB; MacLellan WR; Fonarow GC
J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
[TBL] [Abstract][Full Text] [Related]
14. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
Singh TP; Almond C
J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
[No Abstract] [Full Text] [Related]
15. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
[TBL] [Abstract][Full Text] [Related]
16. [Beta-blocker therapy for chronic heart failure in patients with dilated cardiomyopathy].
Hori M; Kagiya T; Sato H; Kitabatake A
Kokyu To Junkan; 1990 Dec; 38(12):1203-9. PubMed ID: 1981100
[No Abstract] [Full Text] [Related]
17. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.
Ward RP; Leeper NJ; Kirkpatrick JN; Lang RM; Sorrentino MJ; Williams KA
Int J Cardiol; 2005 Oct; 104(3):264-8. PubMed ID: 16186054
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy is associated with lower mortality among patients with severe heart failure.
Mozaffarian D; Nye R; Levy WC
Am J Cardiol; 2004 May; 93(9):1124-9. PubMed ID: 15110204
[TBL] [Abstract][Full Text] [Related]
19. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
[TBL] [Abstract][Full Text] [Related]
20. Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms.
Lipinski MJ; Abbate A; Fuster V; Vetrovec GW
Nat Clin Pract Cardiovasc Med; 2007 Apr; 4(4):196-205. PubMed ID: 17380165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
